ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

In Their Own Words: A 64-page Internal Report with over 1,500 Faculty Comments on MD Anderson Morale

March 29, 2013

Advisors Ok New RFP For Natural Product Large-Scale Production

March 6, 1992

ACS Expresses Concern About “Fletcher Report” On Mammography

May 7, 1993

“Exciting” Developments In Diagnosis, Screening Methods Reported By Berlin As He Leaves NCI Post

April 11, 1975

More Than 300 request RFP for New Community Oncology Program

May 25, 1979

In Brief: Appropriations Markup Delayed Until September; FCRC Recompetition Draws 94 Requests for RFP

July 31, 1981